Tecvayli 153 mg/1.7 mL (90 mg/mL) injection Images
Generic Name: teclistamab
This medication has been identified as Tecvayli 153 mg/1.7 mL (90 mg/mL) injection. It is supplied by Janssen Biotech, Inc.
Tecvayli is used in the treatment of Multiple Myeloma and belongs to the drug class bispecific T-cell engagers (BiTE). Tecvayli 153 mg/1.7 mL (90 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Tecvayli
- Generic Name
- teclistamab
- Strength
- 153 mg/1.7 mL (90 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Bispecific T-cell engagers (BiTE)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Biotech, Inc.
- National Drug Code (NDC)
- 57894-0450
More about Tecvayli (teclistamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.